Advertisement

Index by Author

March 1999; 48 (3)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Ablamunits, V

    • Specific gene expression in pancreatic beta-cells: cloning and characterization of differentially expressed genes. Diabetes March 1999 48:552-556; doi:10.2337/diabetes.48.3.552

  2. Adamsky, K

    • Specific gene expression in pancreatic beta-cells: cloning and characterization of differentially expressed genes. Diabetes March 1999 48:552-556; doi:10.2337/diabetes.48.3.552

  3. Albu, J

    • Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes March 1999 48:635-639; doi:10.2337/diabetes.48.3.635

  4. Alcolado, J C

    • Phylogenetic analysis of mitochondrial DNA in type 2 diabetes: maternal history and ancient population expansion. Diabetes March 1999 48:628-634; doi:10.2337/diabetes.48.3.628

  5. Allison, D B

    • Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes March 1999 48:635-639; doi:10.2337/diabetes.48.3.635

  6. Arava, Y

    • Specific gene expression in pancreatic beta-cells: cloning and characterization of differentially expressed genes. Diabetes March 1999 48:552-556; doi:10.2337/diabetes.48.3.552

  7. Arden, S D

    • Molecular cloning of a pancreatic islet-specific glucose-6-phosphatase catalytic subunit-related protein. Diabetes March 1999 48:531-542; doi:10.2337/diabetes.48.3.531

  8. Ashley, R H

    • The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes March 1999 48:491-498; doi:10.2337/diabetes.48.3.491

B

  1. Barker, C F

    • Prevention of autoimmune recurrence and rejection by adenovirus-mediated CTLA4Ig gene transfer to the pancreatic graft in BB rat. Diabetes March 1999 48:652-657; doi:10.2337/diabetes.48.3.652

  2. Barrett, E J

    • Acute vasoconstriction-induced insulin resistance in rat muscle in vivo. Diabetes March 1999 48:564-569; doi:10.2337/diabetes.48.3.564

  3. Bektas, A

    • Exclusion of insulin receptor substrate 2 (IRS-2) as a major locus for early-onset autosomal dominant type 2 diabetes. Diabetes March 1999 48:640-642; doi:10.2337/diabetes.48.3.640

  4. Bergman, B

    • Molecular cloning of a pancreatic islet-specific glucose-6-phosphatase catalytic subunit-related protein. Diabetes March 1999 48:531-542; doi:10.2337/diabetes.48.3.531

  5. Bischof, L J

    • Structure and promoter activity of an islet-specific glucose-6-phosphatase catalytic subunit-related gene. Diabetes March 1999 48:543-551; doi:10.2337/diabetes.48.3.543

  6. Blangero, J

    • The quantitative trait locus on chromosome 2 for serum leptin levels is confirmed in African-Americans. Diabetes March 1999 48:643-644; doi:10.2337/diabetes.48.3.643

  7. Boden, G

    • Effects of fatty acids and ketone bodies on basal insulin secretion in type 2 diabetes. Diabetes March 1999 48:577-583; doi:10.2337/diabetes.48.3.577

  8. Bondjers, G

    • Fatty acids modulate the composition of extracellular matrix in cultured human arterial smooth muscle cells by altering the expression of genes for proteoglycan core proteins. Diabetes March 1999 48:616-622; doi:10.2337/diabetes.48.3.616

  9. Bonifacio, E

    • Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes March 1999 48:460-468; doi:10.2337/diabetes.48.3.460

  10. Bonner-Weir, S

    • The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration. Diabetes March 1999 48:507-513; doi:10.2337/diabetes.48.3.507

  11. Borg, M A

    • Chronic hypoglycemia and diabetes impair counterregulation induced by localized 2-deoxy-glucose perfusion of the ventromedial hypothalamus in rats. Diabetes March 1999 48:584-587; doi:10.2337/diabetes.48.3.584

  12. Borg, W P

    • Chronic hypoglycemia and diabetes impair counterregulation induced by localized 2-deoxy-glucose perfusion of the ventromedial hypothalamus in rats. Diabetes March 1999 48:584-587; doi:10.2337/diabetes.48.3.584

  13. Born, J

    • Central nervous system effects of intranasally administered insulin during euglycemia in men. Diabetes March 1999 48:557-563; doi:10.2337/diabetes.48.3.557

  14. Bremer, T

    • Is blood glucose predictable from previous values? A solicitation for data. Diabetes March 1999 48:445-451; doi:10.2337/diabetes.48.3.445

  15. Brines, M L

    • Chronic hypoglycemia and diabetes impair counterregulation induced by localized 2-deoxy-glucose perfusion of the ventromedial hypothalamus in rats. Diabetes March 1999 48:584-587; doi:10.2337/diabetes.48.3.584

  16. Brun, A M

    • Site-specific phosphorylation of synapsin I by Ca2+/calmodulin-dependent protein kinase II in pancreatic betaTC3 cells: synapsin I is not associated with insulin secretory granules. Diabetes March 1999 48:499-506; doi:10.2337/diabetes.48.3.499

  17. Burn, P

    • Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes March 1999 48:635-639; doi:10.2337/diabetes.48.3.635

  18. Buse, M G

    • Hyperglycemia inhibits insulin activation of Akt/protein kinase B but not phosphatidylinositol 3-kinase in rat skeletal muscle. Diabetes March 1999 48:658-663; doi:10.2337/diabetes.48.3.658

  19. Butler, P C

    • The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes March 1999 48:491-498; doi:10.2337/diabetes.48.3.491

C

  1. Camejo, G

    • Fatty acids modulate the composition of extracellular matrix in cultured human arterial smooth muscle cells by altering the expression of genes for proteoglycan core proteins. Diabetes March 1999 48:616-622; doi:10.2337/diabetes.48.3.616

  2. Cao, X

    • Heterogeneous cardiac sympathetic denervation and decreased myocardial nerve growth factor in streptozotocin-induced diabetic rats: implications for cardiac sympathetic dysinnervation complicating diabetes. Diabetes March 1999 48:603-608; doi:10.2337/diabetes.48.3.603

  3. Capocci, P

    • Prevention of autoimmune recurrence and rejection by adenovirus-mediated CTLA4Ig gene transfer to the pancreatic graft in BB rat. Diabetes March 1999 48:652-657; doi:10.2337/diabetes.48.3.652

  4. Carpentier, A

    • Resistance to insulin's acute direct hepatic effect in suppressing steady-state glucose production in individuals with type 2 diabetes. Diabetes March 1999 48:570-576; doi:10.2337/diabetes.48.3.570

  5. Chapman, S C

    • Structure and promoter activity of an islet-specific glucose-6-phosphatase catalytic subunit-related gene. Diabetes March 1999 48:543-551; doi:10.2337/diabetes.48.3.543

  6. Chen, X

    • Effects of fatty acids and ketone bodies on basal insulin secretion in type 2 diabetes. Diabetes March 1999 48:577-583; doi:10.2337/diabetes.48.3.577

  7. Chin, W

    • Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes March 1999 48:635-639; doi:10.2337/diabetes.48.3.635

  8. Claas, F H

    • Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. Diabetes March 1999 48:484-490; doi:10.2337/diabetes.48.3.484

  9. Clark, M G

    • Acute vasoconstriction-induced insulin resistance in rat muscle in vivo. Diabetes March 1999 48:564-569; doi:10.2337/diabetes.48.3.564

  10. Comuzzie, A G

    • The quantitative trait locus on chromosome 2 for serum leptin levels is confirmed in African-Americans. Diabetes March 1999 48:643-644; doi:10.2337/diabetes.48.3.643

  11. Cooper, R S

    • The quantitative trait locus on chromosome 2 for serum leptin levels is confirmed in African-Americans. Diabetes March 1999 48:643-644; doi:10.2337/diabetes.48.3.643

D

  1. Deng, N

    • Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes March 1999 48:635-639; doi:10.2337/diabetes.48.3.635

  2. Deshaies, Y

    • Response of adipose tissue lipoprotein lipase to the cephalic phase of insulin secretion. Diabetes March 1999 48:452-459; doi:10.2337/diabetes.48.3.452

  3. de Vries, R R

    • Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. Diabetes March 1999 48:484-490; doi:10.2337/diabetes.48.3.484

  4. Doria, A

    • Exclusion of insulin receptor substrate 2 (IRS-2) as a major locus for early-onset autosomal dominant type 2 diabetes. Diabetes March 1999 48:640-642; doi:10.2337/diabetes.48.3.640

  5. Duinkerken, G

    • Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. Diabetes March 1999 48:484-490; doi:10.2337/diabetes.48.3.484

  6. Duprat, L

    • Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes March 1999 48:635-639; doi:10.2337/diabetes.48.3.635

E

  1. Easom, R A

    • Site-specific phosphorylation of synapsin I by Ca2+/calmodulin-dependent protein kinase II in pancreatic betaTC3 cells: synapsin I is not associated with insulin secretory granules. Diabetes March 1999 48:499-506; doi:10.2337/diabetes.48.3.499

  2. Ebert, D H

    • Structure and promoter activity of an islet-specific glucose-6-phosphatase catalytic subunit-related gene. Diabetes March 1999 48:543-551; doi:10.2337/diabetes.48.3.543

  3. Efendic, S

    • Muscle fiber type-specific defects in insulin signal transduction to glucose transport in diabetic GK rats. Diabetes March 1999 48:664-670; doi:10.2337/diabetes.48.3.664

  4. Elliott, J F

    • Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice. Diabetes March 1999 48:469-477; doi:10.2337/diabetes.48.3.469

  5. Elsner, M

    • Metabolic regulation, activity state, and intracellular binding of glucokinase in insulin-secreting cells. Diabetes March 1999 48:514-523; doi:10.2337/diabetes.48.3.514

  6. Enderle, M D

    • Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes. Diabetes March 1999 48:623-627; doi:10.2337/diabetes.48.3.623

  7. Ezerzer, C

    • Specific gene expression in pancreatic beta-cells: cloning and characterization of differentially expressed genes. Diabetes March 1999 48:552-556; doi:10.2337/diabetes.48.3.552

F

  1. Fehm, H L

    • Central nervous system effects of intranasally administered insulin during euglycemia in men. Diabetes March 1999 48:557-563; doi:10.2337/diabetes.48.3.557

  2. Fisher, S L

    • Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes March 1999 48:635-639; doi:10.2337/diabetes.48.3.635

  3. Forman, L A

    • Heterogeneous cardiac sympathetic denervation and decreased myocardial nerve growth factor in streptozotocin-induced diabetic rats: implications for cardiac sympathetic dysinnervation complicating diabetes. Diabetes March 1999 48:603-608; doi:10.2337/diabetes.48.3.603

  4. Franco, L S

    • Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes March 1999 48:635-639; doi:10.2337/diabetes.48.3.635

  5. Freed, C R

    • Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes. Diabetes March 1999 48:649-651; doi:10.2337/diabetes.48.3.649

  6. Füllhase, J

    • Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes. Diabetes March 1999 48:623-627; doi:10.2337/diabetes.48.3.623

G

  1. Garcia, K

    • Brain-derived neurotrophic factor improves blood glucose control and alleviates fasting hyperglycemia in C57BLKS-Lepr(db)/lepr(db) mice. Diabetes March 1999 48:588-594; doi:10.2337/diabetes.48.3.588

  2. Giacca, A

    • Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats. Diabetes March 1999 48:524-530; doi:10.2337/diabetes.48.3.524
    • Resistance to insulin's acute direct hepatic effect in suppressing steady-state glucose production in individuals with type 2 diabetes. Diabetes March 1999 48:570-576; doi:10.2337/diabetes.48.3.570

  3. Gill-Randall, R

    • Phylogenetic analysis of mitochondrial DNA in type 2 diabetes: maternal history and ancient population expansion. Diabetes March 1999 48:628-634; doi:10.2337/diabetes.48.3.628

  4. Goh, T

    • Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats. Diabetes March 1999 48:524-530; doi:10.2337/diabetes.48.3.524

  5. Goldman, J K

    • Structure and promoter activity of an islet-specific glucose-6-phosphatase catalytic subunit-related gene. Diabetes March 1999 48:543-551; doi:10.2337/diabetes.48.3.543

  6. Gough, D A

    • Is blood glucose predictable from previous values? A solicitation for data. Diabetes March 1999 48:445-451; doi:10.2337/diabetes.48.3.445

  7. Gupta, N

    • Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats. Diabetes March 1999 48:524-530; doi:10.2337/diabetes.48.3.524

  8. Gu, W

    • Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes March 1999 48:635-639; doi:10.2337/diabetes.48.3.635

H

  1. Habener, J F

    • The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration. Diabetes March 1999 48:507-513; doi:10.2337/diabetes.48.3.507

  2. Haneda, M

    • Stretch-induced overproduction of fibronectin in mesangial cells is mediated by the activation of mitogen-activated protein kinase. Diabetes March 1999 48:595-602; doi:10.2337/diabetes.48.3.595

  3. Häring, H U

    • Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes. Diabetes March 1999 48:623-627; doi:10.2337/diabetes.48.3.623

  4. Harrison, D

    • The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes March 1999 48:491-498; doi:10.2337/diabetes.48.3.491

  5. Heydrick, S J

    • Hyperglycemia inhibits insulin activation of Akt/protein kinase B but not phosphatidylinositol 3-kinase in rat skeletal muscle. Diabetes March 1999 48:658-663; doi:10.2337/diabetes.48.3.658

  6. Heymsfield, S

    • Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes March 1999 48:635-639; doi:10.2337/diabetes.48.3.635

  7. Hisatome, I

    • Hemodynamic basis for the acute cardiac effects of troglitazone in isolated perfused rat hearts. Diabetes March 1999 48:609-615; doi:10.2337/diabetes.48.3.609

  8. Hummel, M

    • Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes March 1999 48:460-468; doi:10.2337/diabetes.48.3.460

  9. Hurlbert, M S

    • Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes. Diabetes March 1999 48:649-651; doi:10.2337/diabetes.48.3.649

  10. Hutton, J C

    • Molecular cloning of a pancreatic islet-specific glucose-6-phosphatase catalytic subunit-related protein. Diabetes March 1999 48:531-542; doi:10.2337/diabetes.48.3.531
    • Structure and promoter activity of an islet-specific glucose-6-phosphatase catalytic subunit-related gene. Diabetes March 1999 48:543-551; doi:10.2337/diabetes.48.3.543
    • Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes. Diabetes March 1999 48:649-651; doi:10.2337/diabetes.48.3.649

I

  1. Ichikawa, F

    • Essential role of caspase-3 in apoptosis of mouse beta-cells transfected with human Fas. Diabetes March 1999 48:478-483; doi:10.2337/diabetes.48.3.478

  2. Ikeda, T

    • Hemodynamic basis for the acute cardiac effects of troglitazone in isolated perfused rat hearts. Diabetes March 1999 48:609-615; doi:10.2337/diabetes.48.3.609

  3. Ings, E I

    • Site-specific phosphorylation of synapsin I by Ca2+/calmodulin-dependent protein kinase II in pancreatic betaTC3 cells: synapsin I is not associated with insulin secretory granules. Diabetes March 1999 48:499-506; doi:10.2337/diabetes.48.3.499

  4. Inoue, I

    • Identification of mutations in the hepatocyte nuclear factor-1alpha gene in Japanese subjects with early-onset NIDDM and functional analysis of the mutant proteins. Diabetes March 1999 48:645-648; doi:10.2337/diabetes.48.3.645

  5. Ishida, T

    • Stretch-induced overproduction of fibronectin in mesangial cells is mediated by the activation of mitogen-activated protein kinase. Diabetes March 1999 48:595-602; doi:10.2337/diabetes.48.3.595

  6. Ishiyama-Shigemoto, S

    • Essential role of caspase-3 in apoptosis of mouse beta-cells transfected with human Fas. Diabetes March 1999 48:478-483; doi:10.2337/diabetes.48.3.478

  7. Iwatani, N

    • Identification of mutations in the hepatocyte nuclear factor-1alpha gene in Japanese subjects with early-onset NIDDM and functional analysis of the mutant proteins. Diabetes March 1999 48:645-648; doi:10.2337/diabetes.48.3.645

J

  1. Jackson, C

    • Brain-derived neurotrophic factor improves blood glucose control and alleviates fasting hyperglycemia in C57BLKS-Lepr(db)/lepr(db) mice. Diabetes March 1999 48:588-594; doi:10.2337/diabetes.48.3.588

  2. Janson, J

    • The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes March 1999 48:491-498; doi:10.2337/diabetes.48.3.491

  3. Jevnikar, A M

    • Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice. Diabetes March 1999 48:469-477; doi:10.2337/diabetes.48.3.469

K

  1. Kaddis, F G

    • Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes. Diabetes March 1999 48:649-651; doi:10.2337/diabetes.48.3.649

  2. Karsch, K R

    • Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes. Diabetes March 1999 48:623-627; doi:10.2337/diabetes.48.3.623

  3. Kawano, Y

    • Muscle fiber type-specific defects in insulin signal transduction to glucose transport in diabetic GK rats. Diabetes March 1999 48:664-670; doi:10.2337/diabetes.48.3.664

  4. Kern, W

    • Central nervous system effects of intranasally administered insulin during euglycemia in men. Diabetes March 1999 48:557-563; doi:10.2337/diabetes.48.3.557

  5. Keymeulen, B

    • Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. Diabetes March 1999 48:484-490; doi:10.2337/diabetes.48.3.484

  6. Kikkawa, R

    • Stretch-induced overproduction of fibronectin in mesangial cells is mediated by the activation of mitogen-activated protein kinase. Diabetes March 1999 48:595-602; doi:10.2337/diabetes.48.3.595

  7. Kissebah, A

    • Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes March 1999 48:635-639; doi:10.2337/diabetes.48.3.635

  8. Kito, Y

    • Identification of mutations in the hepatocyte nuclear factor-1alpha gene in Japanese subjects with early-onset NIDDM and functional analysis of the mutant proteins. Diabetes March 1999 48:645-648; doi:10.2337/diabetes.48.3.645

  9. Kleyn, P W

    • Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes March 1999 48:635-639; doi:10.2337/diabetes.48.3.635

  10. Koch, M

    • Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes. Diabetes March 1999 48:623-627; doi:10.2337/diabetes.48.3.623

  11. Koya, D

    • Stretch-induced overproduction of fibronectin in mesangial cells is mediated by the activation of mitogen-activated protein kinase. Diabetes March 1999 48:595-602; doi:10.2337/diabetes.48.3.595

  12. Krolewski, A S

    • Exclusion of insulin receptor substrate 2 (IRS-2) as a major locus for early-onset autosomal dominant type 2 diabetes. Diabetes March 1999 48:640-642; doi:10.2337/diabetes.48.3.640

  13. Krook, A

    • Muscle fiber type-specific defects in insulin signal transduction to glucose transport in diabetic GK rats. Diabetes March 1999 48:664-670; doi:10.2337/diabetes.48.3.664

  14. Krueger, K A

    • Site-specific phosphorylation of synapsin I by Ca2+/calmodulin-dependent protein kinase II in pancreatic betaTC3 cells: synapsin I is not associated with insulin secretory granules. Diabetes March 1999 48:499-506; doi:10.2337/diabetes.48.3.499

  15. Kühn, R

    • Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes. Diabetes March 1999 48:623-627; doi:10.2337/diabetes.48.3.623

  16. Kurowski, T G

    • Hyperglycemia inhibits insulin activation of Akt/protein kinase B but not phosphatidylinositol 3-kinase in rat skeletal muscle. Diabetes March 1999 48:658-663; doi:10.2337/diabetes.48.3.658

L

  1. Landt, M

    • Site-specific phosphorylation of synapsin I by Ca2+/calmodulin-dependent protein kinase II in pancreatic betaTC3 cells: synapsin I is not associated with insulin secretory granules. Diabetes March 1999 48:499-506; doi:10.2337/diabetes.48.3.499

  2. Lee, J

    • Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes March 1999 48:635-639; doi:10.2337/diabetes.48.3.635

  3. Leiter, E H

    • Structure and promoter activity of an islet-specific glucose-6-phosphatase catalytic subunit-related gene. Diabetes March 1999 48:543-551; doi:10.2337/diabetes.48.3.543

  4. Lenzen, S

    • Metabolic regulation, activity state, and intracellular binding of glucokinase in insulin-secreting cells. Diabetes March 1999 48:514-523; doi:10.2337/diabetes.48.3.514

  5. Lernmark, A

    • Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. Diabetes March 1999 48:484-490; doi:10.2337/diabetes.48.3.484

  6. Lewis, G F

    • Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats. Diabetes March 1999 48:524-530; doi:10.2337/diabetes.48.3.524
    • Resistance to insulin's acute direct hepatic effect in suppressing steady-state glucose production in individuals with type 2 diabetes. Diabetes March 1999 48:570-576; doi:10.2337/diabetes.48.3.570

  7. Lin, Y

    • Hyperglycemia inhibits insulin activation of Akt/protein kinase B but not phosphatidylinositol 3-kinase in rat skeletal muscle. Diabetes March 1999 48:658-663; doi:10.2337/diabetes.48.3.658

  8. Lissauer, M E

    • The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration. Diabetes March 1999 48:507-513; doi:10.2337/diabetes.48.3.507

  9. Liu, J

    • Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice. Diabetes March 1999 48:469-477; doi:10.2337/diabetes.48.3.469

  10. Liu, X

    • Brain-derived neurotrophic factor improves blood glucose control and alleviates fasting hyperglycemia in C57BLKS-Lepr(db)/lepr(db) mice. Diabetes March 1999 48:588-594; doi:10.2337/diabetes.48.3.588

  11. Lowe, W L

    • The quantitative trait locus on chromosome 2 for serum leptin levels is confirmed in African-Americans. Diabetes March 1999 48:643-644; doi:10.2337/diabetes.48.3.643

  12. Luke, A

    • The quantitative trait locus on chromosome 2 for serum leptin levels is confirmed in African-Americans. Diabetes March 1999 48:643-644; doi:10.2337/diabetes.48.3.643

  13. Luo, Z

    • Hyperglycemia inhibits insulin activation of Akt/protein kinase B but not phosphatidylinositol 3-kinase in rat skeletal muscle. Diabetes March 1999 48:658-663; doi:10.2337/diabetes.48.3.658

M

  1. Mabe, H

    • Identification of mutations in the hepatocyte nuclear factor-1alpha gene in Japanese subjects with early-onset NIDDM and functional analysis of the mutant proteins. Diabetes March 1999 48:645-648; doi:10.2337/diabetes.48.3.645

  2. Maeda, S

    • Stretch-induced overproduction of fibronectin in mesangial cells is mediated by the activation of mitogen-activated protein kinase. Diabetes March 1999 48:595-602; doi:10.2337/diabetes.48.3.595

  3. Maruti, S

    • Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes March 1999 48:635-639; doi:10.2337/diabetes.48.3.635

  4. Mason, T M

    • Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats. Diabetes March 1999 48:524-530; doi:10.2337/diabetes.48.3.524

  5. Mathews, C E

    • Structure and promoter activity of an islet-specific glucose-6-phosphatase catalytic subunit-related gene. Diabetes March 1999 48:543-551; doi:10.2337/diabetes.48.3.543

  6. McIntyre, S

    • The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes March 1999 48:491-498; doi:10.2337/diabetes.48.3.491

  7. Miller, C P

    • The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration. Diabetes March 1999 48:507-513; doi:10.2337/diabetes.48.3.507

  8. Morikawa, A

    • Identification of mutations in the hepatocyte nuclear factor-1alpha gene in Japanese subjects with early-onset NIDDM and functional analysis of the mutant proteins. Diabetes March 1999 48:645-648; doi:10.2337/diabetes.48.3.645

  9. Moriya, N

    • Identification of mutations in the hepatocyte nuclear factor-1alpha gene in Japanese subjects with early-onset NIDDM and functional analysis of the mutant proteins. Diabetes March 1999 48:645-648; doi:10.2337/diabetes.48.3.645

  10. Muroya, K

    • Identification of mutations in the hepatocyte nuclear factor-1alpha gene in Japanese subjects with early-onset NIDDM and functional analysis of the mutant proteins. Diabetes March 1999 48:645-648; doi:10.2337/diabetes.48.3.645

N

  1. Naïmi, N

    • Response of adipose tissue lipoprotein lipase to the cephalic phase of insulin secretion. Diabetes March 1999 48:452-459; doi:10.2337/diabetes.48.3.452

  2. Naji, A

    • Prevention of autoimmune recurrence and rejection by adenovirus-mediated CTLA4Ig gene transfer to the pancreatic graft in BB rat. Diabetes March 1999 48:652-657; doi:10.2337/diabetes.48.3.652

  3. Nathan, J

    • Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes March 1999 48:635-639; doi:10.2337/diabetes.48.3.635

  4. Nishigori, H

    • Identification of mutations in the hepatocyte nuclear factor-1alpha gene in Japanese subjects with early-onset NIDDM and functional analysis of the mutant proteins. Diabetes March 1999 48:645-648; doi:10.2337/diabetes.48.3.645

  5. Nonaka, K

    • Essential role of caspase-3 in apoptosis of mouse beta-cells transfected with human Fas. Diabetes March 1999 48:478-483; doi:10.2337/diabetes.48.3.478

O

  1. O'Brien, R M

    • Molecular cloning of a pancreatic islet-specific glucose-6-phosphatase catalytic subunit-related protein. Diabetes March 1999 48:531-542; doi:10.2337/diabetes.48.3.531
    • Structure and promoter activity of an islet-specific glucose-6-phosphatase catalytic subunit-related gene. Diabetes March 1999 48:543-551; doi:10.2337/diabetes.48.3.543

  2. Ogata, T

    • Identification of mutations in the hepatocyte nuclear factor-1alpha gene in Japanese subjects with early-onset NIDDM and functional analysis of the mutant proteins. Diabetes March 1999 48:645-648; doi:10.2337/diabetes.48.3.645

  3. Ogino, K

    • Hemodynamic basis for the acute cardiac effects of troglitazone in isolated perfused rat hearts. Diabetes March 1999 48:609-615; doi:10.2337/diabetes.48.3.609

  4. Olsson, U

    • Fatty acids modulate the composition of extracellular matrix in cultured human arterial smooth muscle cells by altering the expression of genes for proteoglycan core proteins. Diabetes March 1999 48:616-622; doi:10.2337/diabetes.48.3.616

  5. Onigata, K

    • Identification of mutations in the hepatocyte nuclear factor-1alpha gene in Japanese subjects with early-onset NIDDM and functional analysis of the mutant proteins. Diabetes March 1999 48:645-648; doi:10.2337/diabetes.48.3.645

  6. Ono, M

    • Brain-derived neurotrophic factor improves blood glucose control and alleviates fasting hyperglycemia in C57BLKS-Lepr(db)/lepr(db) mice. Diabetes March 1999 48:588-594; doi:10.2337/diabetes.48.3.588

P

  1. Pfohl, M

    • Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes. Diabetes March 1999 48:623-627; doi:10.2337/diabetes.48.3.623

  2. Picard, F

    • Response of adipose tissue lipoprotein lipase to the cephalic phase of insulin secretion. Diabetes March 1999 48:452-459; doi:10.2337/diabetes.48.3.452

  3. Pipeleers, D

    • Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. Diabetes March 1999 48:484-490; doi:10.2337/diabetes.48.3.484

  4. Pi-Sunyer, F X

    • Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes March 1999 48:635-639; doi:10.2337/diabetes.48.3.635

  5. Purdy, L E

    • Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice. Diabetes March 1999 48:469-477; doi:10.2337/diabetes.48.3.469

R

  1. Rabinovitch, S

    • Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice. Diabetes March 1999 48:469-477; doi:10.2337/diabetes.48.3.469

  2. Rattigan, S

    • Acute vasoconstriction-induced insulin resistance in rat muscle in vivo. Diabetes March 1999 48:564-569; doi:10.2337/diabetes.48.3.564

  3. Reitz, P

    • The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration. Diabetes March 1999 48:507-513; doi:10.2337/diabetes.48.3.507

  4. Richard, D

    • Response of adipose tissue lipoprotein lipase to the cephalic phase of insulin secretion. Diabetes March 1999 48:452-459; doi:10.2337/diabetes.48.3.452

  5. Roep, B O

    • Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. Diabetes March 1999 48:484-490; doi:10.2337/diabetes.48.3.484

  6. Rostami, S

    • Prevention of autoimmune recurrence and rejection by adenovirus-mediated CTLA4Ig gene transfer to the pancreatic graft in BB rat. Diabetes March 1999 48:652-657; doi:10.2337/diabetes.48.3.652

  7. Roth, R A

    • Muscle fiber type-specific defects in insulin signal transduction to glucose transport in diabetic GK rats. Diabetes March 1999 48:664-670; doi:10.2337/diabetes.48.3.664

  8. Rotimi, C N

    • The quantitative trait locus on chromosome 2 for serum leptin levels is confirmed in African-Americans. Diabetes March 1999 48:643-644; doi:10.2337/diabetes.48.3.643

  9. Ruderman, N B

    • Hyperglycemia inhibits insulin activation of Akt/protein kinase B but not phosphatidylinositol 3-kinase in rat skeletal muscle. Diabetes March 1999 48:658-663; doi:10.2337/diabetes.48.3.658

  10. Ryder, J W

    • Muscle fiber type-specific defects in insulin signal transduction to glucose transport in diabetic GK rats. Diabetes March 1999 48:664-670; doi:10.2337/diabetes.48.3.664

S

  1. Sandhu, H

    • Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats. Diabetes March 1999 48:524-530; doi:10.2337/diabetes.48.3.524

  2. Schenker, M

    • Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes March 1999 48:460-468; doi:10.2337/diabetes.48.3.460

  3. Schmid, H

    • Heterogeneous cardiac sympathetic denervation and decreased myocardial nerve growth factor in streptozotocin-induced diabetic rats: implications for cardiac sympathetic dysinnervation complicating diabetes. Diabetes March 1999 48:603-608; doi:10.2337/diabetes.48.3.603

  4. Schreiber, H

    • Central nervous system effects of intranasally administered insulin during euglycemia in men. Diabetes March 1999 48:557-563; doi:10.2337/diabetes.48.3.557

  5. Sharma, A

    • The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration. Diabetes March 1999 48:507-513; doi:10.2337/diabetes.48.3.507

  6. Sherman, P S

    • Heterogeneous cardiac sympathetic denervation and decreased myocardial nerve growth factor in streptozotocin-induced diabetic rats: implications for cardiac sympathetic dysinnervation complicating diabetes. Diabetes March 1999 48:603-608; doi:10.2337/diabetes.48.3.603

  7. Sherratt, E J

    • Phylogenetic analysis of mitochondrial DNA in type 2 diabetes: maternal history and ancient population expansion. Diabetes March 1999 48:628-634; doi:10.2337/diabetes.48.3.628

  8. Sherwin, R S

    • Chronic hypoglycemia and diabetes impair counterregulation induced by localized 2-deoxy-glucose perfusion of the ventromedial hypothalamus in rats. Diabetes March 1999 48:584-587; doi:10.2337/diabetes.48.3.584

  9. Shimoyama, M

    • Hemodynamic basis for the acute cardiac effects of troglitazone in isolated perfused rat hearts. Diabetes March 1999 48:609-615; doi:10.2337/diabetes.48.3.609

  10. Sho, K

    • Identification of mutations in the hepatocyte nuclear factor-1alpha gene in Japanese subjects with early-onset NIDDM and functional analysis of the mutant proteins. Diabetes March 1999 48:645-648; doi:10.2337/diabetes.48.3.645

  11. Shulman, G I

    • Chronic hypoglycemia and diabetes impair counterregulation induced by localized 2-deoxy-glucose perfusion of the ventromedial hypothalamus in rats. Diabetes March 1999 48:584-587; doi:10.2337/diabetes.48.3.584

  12. Song, X M

    • Muscle fiber type-specific defects in insulin signal transduction to glucose transport in diabetic GK rats. Diabetes March 1999 48:664-670; doi:10.2337/diabetes.48.3.664

  13. Steegers, S

    • Molecular cloning of a pancreatic islet-specific glucose-6-phosphatase catalytic subunit-related protein. Diabetes March 1999 48:531-542; doi:10.2337/diabetes.48.3.531

  14. Steffeck, H

    • Metabolic regulation, activity state, and intracellular binding of glucokinase in insulin-secreting cells. Diabetes March 1999 48:514-523; doi:10.2337/diabetes.48.3.514

  15. Stevens, M J

    • Heterogeneous cardiac sympathetic denervation and decreased myocardial nerve growth factor in streptozotocin-induced diabetic rats: implications for cardiac sympathetic dysinnervation complicating diabetes. Diabetes March 1999 48:603-608; doi:10.2337/diabetes.48.3.603

  16. Stobbe, I

    • Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. Diabetes March 1999 48:484-490; doi:10.2337/diabetes.48.3.484

  17. Streeper, R S

    • Structure and promoter activity of an islet-specific glucose-6-phosphatase catalytic subunit-related gene. Diabetes March 1999 48:543-551; doi:10.2337/diabetes.48.3.543

  18. Svitek, C A

    • Structure and promoter activity of an islet-specific glucose-6-phosphatase catalytic subunit-related gene. Diabetes March 1999 48:543-551; doi:10.2337/diabetes.48.3.543

T

  1. Takeda, J

    • Identification of mutations in the hepatocyte nuclear factor-1alpha gene in Japanese subjects with early-onset NIDDM and functional analysis of the mutant proteins. Diabetes March 1999 48:645-648; doi:10.2337/diabetes.48.3.645

  2. Takumi, T

    • Identification of mutations in the hepatocyte nuclear factor-1alpha gene in Japanese subjects with early-onset NIDDM and functional analysis of the mutant proteins. Diabetes March 1999 48:645-648; doi:10.2337/diabetes.48.3.645

  3. Tamborlane, W V

    • Chronic hypoglycemia and diabetes impair counterregulation induced by localized 2-deoxy-glucose perfusion of the ventromedial hypothalamus in rats. Diabetes March 1999 48:584-587; doi:10.2337/diabetes.48.3.584

  4. Tanaka, Y

    • Hemodynamic basis for the acute cardiac effects of troglitazone in isolated perfused rat hearts. Diabetes March 1999 48:609-615; doi:10.2337/diabetes.48.3.609

  5. Taneja, M

    • The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration. Diabetes March 1999 48:507-513; doi:10.2337/diabetes.48.3.507

  6. Tchipashvili, V

    • Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats. Diabetes March 1999 48:524-530; doi:10.2337/diabetes.48.3.524

  7. Thomas, A W

    • Phylogenetic analysis of mitochondrial DNA in type 2 diabetes: maternal history and ancient population expansion. Diabetes March 1999 48:628-634; doi:10.2337/diabetes.48.3.628

  8. Tiedge, M

    • Metabolic regulation, activity state, and intracellular binding of glucokinase in insulin-secreting cells. Diabetes March 1999 48:514-523; doi:10.2337/diabetes.48.3.514

  9. Tomura, H

    • Identification of mutations in the hepatocyte nuclear factor-1alpha gene in Japanese subjects with early-onset NIDDM and functional analysis of the mutant proteins. Diabetes March 1999 48:645-648; doi:10.2337/diabetes.48.3.645

  10. Tonra, J R

    • Brain-derived neurotrophic factor improves blood glucose control and alleviates fasting hyperglycemia in C57BLKS-Lepr(db)/lepr(db) mice. Diabetes March 1999 48:588-594; doi:10.2337/diabetes.48.3.588

  11. Tsichlis, P N

    • Hyperglycemia inhibits insulin activation of Akt/protein kinase B but not phosphatidylinositol 3-kinase in rat skeletal muscle. Diabetes March 1999 48:658-663; doi:10.2337/diabetes.48.3.658

  12. Tu, Z

    • Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes March 1999 48:635-639; doi:10.2337/diabetes.48.3.635

U

  1. Uchikoshi, F

    • Prevention of autoimmune recurrence and rejection by adenovirus-mediated CTLA4Ig gene transfer to the pancreatic graft in BB rat. Diabetes March 1999 48:652-657; doi:10.2337/diabetes.48.3.652

V

  1. van Rood, J J

    • Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. Diabetes March 1999 48:484-490; doi:10.2337/diabetes.48.3.484

  2. Vranic, M

    • Resistance to insulin's acute direct hepatic effect in suppressing steady-state glucose production in individuals with type 2 diabetes. Diabetes March 1999 48:570-576; doi:10.2337/diabetes.48.3.570

W

  1. Walker, M D

    • Specific gene expression in pancreatic beta-cells: cloning and characterization of differentially expressed genes. Diabetes March 1999 48:552-556; doi:10.2337/diabetes.48.3.552

  2. Wallberg-Henriksson, H

    • Muscle fiber type-specific defects in insulin signal transduction to glucose transport in diabetic GK rats. Diabetes March 1999 48:664-670; doi:10.2337/diabetes.48.3.664

  3. Warram, J H

    • Exclusion of insulin receptor substrate 2 (IRS-2) as a major locus for early-onset autosomal dominant type 2 diabetes. Diabetes March 1999 48:640-642; doi:10.2337/diabetes.48.3.640

  4. Wasmeier, C

    • Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes. Diabetes March 1999 48:649-651; doi:10.2337/diabetes.48.3.649

  5. Webb, S

    • Molecular cloning of a pancreatic islet-specific glucose-6-phosphatase catalytic subunit-related protein. Diabetes March 1999 48:531-542; doi:10.2337/diabetes.48.3.531

  6. Weir, G C

    • The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration. Diabetes March 1999 48:507-513; doi:10.2337/diabetes.48.3.507

  7. White, M F

    • Exclusion of insulin receptor substrate 2 (IRS-2) as a major locus for early-onset autosomal dominant type 2 diabetes. Diabetes March 1999 48:640-642; doi:10.2337/diabetes.48.3.640

  8. Wiegand, S J

    • Brain-derived neurotrophic factor improves blood glucose control and alleviates fasting hyperglycemia in C57BLKS-Lepr(db)/lepr(db) mice. Diabetes March 1999 48:588-594; doi:10.2337/diabetes.48.3.588

  9. Wong, V

    • Brain-derived neurotrophic factor improves blood glucose control and alleviates fasting hyperglycemia in C57BLKS-Lepr(db)/lepr(db) mice. Diabetes March 1999 48:588-594; doi:10.2337/diabetes.48.3.588

Y

  1. Yagaloff, K A

    • Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes March 1999 48:635-639; doi:10.2337/diabetes.48.3.635

  2. Yamada, K

    • Essential role of caspase-3 in apoptosis of mouse beta-cells transfected with human Fas. Diabetes March 1999 48:478-483; doi:10.2337/diabetes.48.3.478

  3. Yamada, S

    • Identification of mutations in the hepatocyte nuclear factor-1alpha gene in Japanese subjects with early-onset NIDDM and functional analysis of the mutant proteins. Diabetes March 1999 48:645-648; doi:10.2337/diabetes.48.3.645

  4. Yancopoulos, G D

    • Brain-derived neurotrophic factor improves blood glucose control and alleviates fasting hyperglycemia in C57BLKS-Lepr(db)/lepr(db) mice. Diabetes March 1999 48:588-594; doi:10.2337/diabetes.48.3.588

  5. Yang, Z D

    • Prevention of autoimmune recurrence and rejection by adenovirus-mediated CTLA4Ig gene transfer to the pancreatic graft in BB rat. Diabetes March 1999 48:652-657; doi:10.2337/diabetes.48.3.652

  6. Yokoi, Y

    • Prevention of autoimmune recurrence and rejection by adenovirus-mediated CTLA4Ig gene transfer to the pancreatic graft in BB rat. Diabetes March 1999 48:652-657; doi:10.2337/diabetes.48.3.652

  7. Yuan, X

    • Essential role of caspase-3 in apoptosis of mouse beta-cells transfected with human Fas. Diabetes March 1999 48:478-483; doi:10.2337/diabetes.48.3.478

Z

  1. Zahn, T

    • Molecular cloning of a pancreatic islet-specific glucose-6-phosphatase catalytic subunit-related protein. Diabetes March 1999 48:531-542; doi:10.2337/diabetes.48.3.531

  2. Zangen, D H

    • The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration. Diabetes March 1999 48:507-513; doi:10.2337/diabetes.48.3.507

  3. Zhou, W

    • Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes. Diabetes March 1999 48:649-651; doi:10.2337/diabetes.48.3.649

  4. Ziegler, A G

    • Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes March 1999 48:460-468; doi:10.2337/diabetes.48.3.460

  5. Zierath, J R

    • Muscle fiber type-specific defects in insulin signal transduction to glucose transport in diabetic GK rats. Diabetes March 1999 48:664-670; doi:10.2337/diabetes.48.3.664

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement